Ligand Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.

CEO

Todd C. Davis

CEOTodd C. Davis

Employees

Employees58

Headquarters

Jupiter, Florida

HeadquartersJupiter, Florida

Founded

1987

Founded1987

Employees

Employees58

LGND Key Statistics

Market cap

1.25B

Market cap1.25B

Price-Earnings ratio

23.96

Price-Earnings ratio23.96

Dividend yield

—

Dividend yield—

Average volume

160.14K

Average volume160.14K

High today

—

High today—

Low today

—

Low today—

Open price

$69.63

Open price$69.63

Volume

0.00

Volume0.00

52 Week high

$94.57

52 Week high$94.57

52 Week low

$49.24

52 Week low$49.24

LGND News

Yahoo Finance 3d

Ligand to Report First Quarter 2024 Financial Results on May 7, 2024 - Yahoo Finance

JUPITER, Fla., April 23, 2024--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report first quarter 2024 financ...